|
JPS4995971A
(enExample)
|
1973-01-27 |
1974-09-11 |
|
|
|
DE2448869A1
(de)
|
1973-10-19 |
1975-09-04 |
Mcneilab Inc |
4-oxo-2-imidazolidinylidenharnstoffe, verfahren zu ihrer herstellung und arzneimittel
|
|
US4025517A
(en)
|
1975-06-23 |
1977-05-24 |
Mcneil Laboratories, Incorporated |
4-Oxo-2-hexahydropyrimidinylidene ureas
|
|
JPS554305A
(en)
*
|
1978-06-13 |
1980-01-12 |
Nippon Zoki Pharmaceut Co Ltd |
Remedy for disease caused by stress and its preparation
|
|
US4864028A
(en)
|
1983-09-14 |
1989-09-05 |
Alcon Laboratories, Inc. |
Spiro-tricyclicaromatic succinimide derivatives
|
|
US5070100A
(en)
*
|
1983-09-14 |
1991-12-03 |
Alcon Laboratories, Inc. |
Spiro-tricyclicaromatic succinimide derivatives
|
|
GB2189698A
(en)
|
1986-04-30 |
1987-11-04 |
Haessle Ab |
Coated omeprazole tablets
|
|
GB2189699A
(en)
|
1986-04-30 |
1987-11-04 |
Haessle Ab |
Coated acid-labile medicaments
|
|
CH677886A5
(enExample)
|
1989-06-26 |
1991-07-15 |
Hans Georg Prof Dr Weder |
|
|
US5387742A
(en)
|
1990-06-15 |
1995-02-07 |
Scios Nova Inc. |
Transgenic mice displaying the amyloid-forming pathology of alzheimer's disease
|
|
ES2236682T5
(es)
|
1991-01-21 |
2011-03-31 |
Elan Pharmaceuticals, Inc. |
Ensayo y modelo para la enfermedad de alzheimer.
|
|
JPH07506720A
(ja)
|
1992-01-07 |
1995-07-27 |
アテナ ニューロサイエンシーズ， インコーポレイテッド |
アルツハイマー病のトランスジェニック動物モデル
|
|
US5604102A
(en)
|
1992-04-15 |
1997-02-18 |
Athena Neurosciences, Inc. |
Methods of screening for β-amyloid peptide production inhibitors
|
|
ES2155099T3
(es)
|
1993-10-27 |
2001-05-01 |
Elan Pharm Inc |
Animales transgenicos que albergan alelos app que presentan una mutacion sueca.
|
|
US5877399A
(en)
|
1994-01-27 |
1999-03-02 |
Johns Hopkins University |
Transgenic mice expressing APP-Swedish mutation develop progressive neurologic disease
|
|
ES2094688B1
(es)
|
1994-08-08 |
1997-08-01 |
Cusi Lab |
Manoemulsion del tipo de aceite en agua, util como vehiculo oftalmico y procedimiento para su preparacion.
|
|
FR2730932B1
(fr)
|
1995-02-27 |
1997-04-04 |
Oreal |
Nanoemulsion transparente a base de lipides amphiphiles non-ioniques fluides et utilisation en cosmetique ou en dermopharmacie
|
|
JPH11507538A
(ja)
|
1995-06-07 |
1999-07-06 |
アテナ ニューロサイエンシズ インコーポレイティド |
β−セクレターゼ、β−セクレターゼに対する抗体、及びβ−セクレターゼ阻害を検出するためのアッセイ
|
|
US5744346A
(en)
|
1995-06-07 |
1998-04-28 |
Athena Neurosciences, Inc. |
β-secretase
|
|
FR2742676B1
(fr)
|
1995-12-21 |
1998-02-06 |
Oreal |
Nanoemulsion transparente a base de tensioactifs silicones et utilisation en cosmetique ou en dermopharmacie
|
|
FR2755854B1
(fr)
|
1996-11-15 |
1998-12-24 |
Oreal |
Nanoemulsion a base de lipides amphiphiles non-ioniques et cationiques et utilisations
|
|
FR2760970B1
(fr)
|
1997-03-18 |
2000-03-10 |
Oreal |
Nanoemulsions a base de lipides amphiphiles non-ioniques et de silicones aminees et utilisations
|
|
WO2000003819A1
(en)
|
1998-07-17 |
2000-01-27 |
The Penn State Research Foundation |
Full form roll finishing technique
|
|
KR100768381B1
(ko)
|
1998-09-24 |
2007-10-18 |
파마시아 앤드 업존 캄파니 엘엘씨 |
알츠하이머병 세크레타제
|
|
FR2787027B1
(fr)
|
1998-12-14 |
2001-01-12 |
Oreal |
Nanoemulsion a base d'esters gras de sucre ou d'ethers gras de sucre et ses utilisations dans les domaines cosmetique, dermatologique et/ou ophtalmologique
|
|
FR2787026B1
(fr)
|
1998-12-14 |
2001-01-12 |
Oreal |
Nanoemulsion a base d'esters mixtes d'acide gras ou d'alcool gras, d'acide carboxylique et de glyceryle, et ses utilisations dans les domaines cosmetique, dermatologique et/ou ophtalmologique
|
|
FR2787326B1
(fr)
|
1998-12-17 |
2001-01-26 |
Oreal |
Nanoemulsion a base d'esters gras de glycerol, et ses utilisations dans les domaines cosmetique, dermatologique et/ou ophtalmologique
|
|
FR2787325B1
(fr)
|
1998-12-17 |
2001-01-26 |
Oreal |
Nanoemulsion a base d'esters gras de sorbitan oxyethylenes ou non oxyethylenes, et ses utilisations dans les domaines cosmetique, dermatologique et/ou ophtalmologique
|
|
FR2787728B1
(fr)
|
1998-12-23 |
2001-01-26 |
Oreal |
Nanoemulsion a base d'esters gras d'acide phosphorique, et ses utilisations dans les domaines cosmetique, dermatologique, pharmaceutique et/ou ophtalmologique
|
|
FR2787703B1
(fr)
|
1998-12-29 |
2001-01-26 |
Oreal |
Nanoemulsion a base d'ethers gras ethoxyles ou d'esters gras ethoxyles, et ses utilisations dans les domaines cosmetique, dermatologique et/ou ophtalmologique
|
|
FR2788007B1
(fr)
|
1999-01-05 |
2001-02-09 |
Oreal |
Nanoemulsion a base de copolymeres blocs d'oxyde d'ethylene et d'oxyde de propylene, et ses utilisations dans les domaines cosmetique, dermatologique et/ou ophtalmologique
|
|
FR2788449B1
(fr)
|
1999-01-14 |
2001-02-16 |
Oreal |
Nanoemulsion a base de citrates d'alkylether, et ses utilisations dans les domaines cosmetique, dermatologique, pharmaceutique et/ou ophtalmologique
|
|
FR2789076B1
(fr)
|
1999-02-02 |
2001-03-02 |
Synthelabo |
Derives de alpha-azacyclomethyl quinoleine, leur preparation et leur application en therapeutique
|
|
US7161962B1
(en)
|
1999-05-27 |
2007-01-09 |
Nuera Communications, Inc. |
Method and apparatus for coding modem signals for transmission over voice networks
|
|
FR2811564B1
(fr)
|
2000-07-13 |
2002-12-27 |
Oreal |
Nanoemulsion contenant des polymeres non ioniques, et ses utilisations notamment dans les domaines cosmetique, dermatologique, pharmaceutique et/ou ophtalmologique
|
|
WO2002055562A2
(en)
|
2001-01-11 |
2002-07-18 |
Eastman Chem Co |
Cyclodextrin sulfonates, guest inclusion complexes, methods of making the same and related materials
|
|
FR2819427B1
(fr)
|
2001-01-18 |
2003-04-11 |
Oreal |
Nanoemulsion translucide, son procede de fabrication et ses utilisations dans les domaines cosmetique, dermatologique et/ou ophtalmologique
|
|
EP2545937A1
(en)
|
2001-06-05 |
2013-01-16 |
The Regents Of The University Of Michigan |
Nanoemulsion vaccines
|
|
US7476393B2
(en)
|
2002-11-29 |
2009-01-13 |
L'oreal |
Process for the preparation of a cationic nanoemulsion, and cosmetic composition
|
|
KR20060058104A
(ko)
|
2003-08-08 |
2006-05-29 |
쉐링 코포레이션 |
벤즈아미드 치환체를 갖는 사이클릭 아민 ｂａｃｅ-1억제제
|
|
EP1660447B1
(en)
|
2003-08-08 |
2008-07-30 |
Schering Corporation |
Cyclic amine bace-1 inhibitors having a heterocyclic substituent
|
|
US7592348B2
(en)
|
2003-12-15 |
2009-09-22 |
Schering Corporation |
Heterocyclic aspartyl protease inhibitors
|
|
US7763609B2
(en)
|
2003-12-15 |
2010-07-27 |
Schering Corporation |
Heterocyclic aspartyl protease inhibitors
|
|
MY148233A
(en)
|
2003-12-15 |
2013-03-29 |
Merck Sharp & Dohme |
Heterocyclic aspartyl protease inhibitors
|
|
US7468402B2
(en)
|
2004-03-17 |
2008-12-23 |
Baker Hughes Incorporated |
Polymeric nanoemulsion as drag reducer for multiphase flow
|
|
AU2005231364A1
(en)
|
2004-04-02 |
2005-10-20 |
Merck & Co., Inc. |
Methods for detecting substances which bind to the amyloid precursor protein or beta amyloid fragments, and binding compounds
|
|
JP2007533741A
(ja)
|
2004-04-22 |
2007-11-22 |
イーライ リリー アンド カンパニー |
Ｂａｃｅ阻害剤
|
|
IL162288A0
(en)
|
2004-06-01 |
2005-11-20 |
Future Products Man S A |
Compositions and methods for treating neurodegenerative disorders
|
|
EP1758907B1
(en)
|
2004-06-16 |
2009-02-18 |
Wyeth |
Diphenylimidazopyrimidine and -imidazole amines as inhibitors of b-secretase
|
|
TW200602045A
(en)
|
2004-06-16 |
2006-01-16 |
Wyeth Corp |
Amino-5, 5-diphenylimidazolone derivatives for the inhibition of β-secretase
|
|
JP2008507538A
(ja)
|
2004-07-22 |
2008-03-13 |
シェーリング コーポレイション |
置換アミドβセクレターゼインヒビター
|
|
DE602005007245D1
(enExample)
|
2004-07-28 |
2008-07-10 |
Schering Corp |
|
|
SV2006002232A
(es)
|
2004-09-21 |
2006-05-25 |
Lilly Co Eli |
Inhibidores bace ref. x-16940
|
|
GB0500683D0
(en)
|
2005-01-13 |
2005-02-23 |
Novartis Ag |
Organic compounds
|
|
US20080132477A1
(en)
|
2005-01-13 |
2008-06-05 |
Claudia Betschart |
Macrocyclic Compounds Useful as Bace Inhibitors
|
|
RU2008100165A
(ru)
|
2005-06-14 |
2009-07-20 |
Шеринг Корпорейшн (US) |
Ингибиторы аспартильных протеаз
|
|
CA2610828A1
(en)
|
2005-06-14 |
2006-12-28 |
Schering Corporation |
Heterocyclic aspartyl protease inhibitors, preparation and use thereof
|
|
PE20070078A1
(es)
|
2005-06-14 |
2007-03-08 |
Schering Corp |
Compuestos heterociclicos macrociclicos como inhibidores de aspartil proteasa
|
|
WO2006138230A2
(en)
|
2005-06-14 |
2006-12-28 |
Schering Corporation |
The preparation and use of protease inhibitors
|
|
US7759353B2
(en)
|
2005-06-14 |
2010-07-20 |
Schering Corporation |
Substituted spiro iminopyrimidinones as aspartyl protease inhibitors, compositions, and methods of treatment
|
|
EP1896477B1
(en)
|
2005-06-14 |
2010-09-22 |
Schering Corporation |
Aspartyl protease inhibitors
|
|
US8110682B2
(en)
|
2005-06-14 |
2012-02-07 |
Schering Corporation |
Preparation and use of compounds as aspartyl protease inhibitors
|
|
TW200738683A
(en)
|
2005-06-30 |
2007-10-16 |
Wyeth Corp |
Amino-5-(5-membered)heteroarylimidazolone compounds and the use thereof for β-secretase modulation
|
|
AU2006266167A1
(en)
*
|
2005-06-30 |
2007-01-11 |
Wyeth |
Amino-5-(6-membered)heteroarylimidazolone compounds and the use thereof for beta-secretase modulation
|
|
TW200730523A
(en)
|
2005-07-29 |
2007-08-16 |
Wyeth Corp |
Cycloalkyl amino-hydantoin compounds and use thereof for β-secretase modulation
|
|
AU2006294620A1
(en)
|
2005-09-26 |
2007-04-05 |
Wyeth |
Amino-5- [4- (difluoromethoxy) phenyl] -5-phenylimidazolone compounds as inhibitors of the beta-secretase (bace)
|
|
US7763606B2
(en)
|
2005-10-27 |
2010-07-27 |
Schering Corporation |
Heterocyclic aspartyl protease inhibitors
|
|
JP2009513670A
(ja)
|
2005-10-31 |
2009-04-02 |
シェーリング コーポレイション |
アスパルチルプロテアーゼインヒビター
|
|
WO2007058601A1
(en)
*
|
2005-11-21 |
2007-05-24 |
Astrazeneca Ab |
Novel 2-amino-imidazole-4-one compounds and their use in the manufacture of a medicament to be used in the treatment of cognitive impairment, alzheimer’s disease, neurodegeneration and dementia
|
|
GB0602951D0
(en)
|
2006-02-14 |
2006-03-29 |
Novartis Ag |
Organic Compounds
|
|
US20090099217A1
(en)
|
2006-04-05 |
2009-04-16 |
Astex Therapeutics Ltd. |
2-Aminopyrimidin-4-Ones And Their Use For Treating Or Preventing Alpha Beta-Related Pathologies
|
|
GB0611064D0
(en)
|
2006-06-05 |
2006-07-12 |
Novartis Ag |
Organic compounds
|
|
RU2009100074A
(ru)
|
2006-06-12 |
2010-07-20 |
Шеринг Корпорейшн (US) |
Гетероциклические ингибиторы аспартильной протеазы
|
|
TW200815447A
(en)
|
2006-06-14 |
2008-04-01 |
Astrazeneca Ab |
Novel compounds IV
|
|
TW200815449A
(en)
|
2006-06-14 |
2008-04-01 |
Astrazeneca Ab |
Novel compounds II
|
|
TW200815443A
(en)
|
2006-06-14 |
2008-04-01 |
Astrazeneca Ab |
Novel compounds I
|
|
TW200808796A
(en)
|
2006-06-14 |
2008-02-16 |
Astrazeneca Ab |
New compounds III
|
|
TW200815349A
(en)
|
2006-06-22 |
2008-04-01 |
Astrazeneca Ab |
New compounds
|
|
RU2009105764A
(ru)
|
2006-07-20 |
2010-08-27 |
Новартис АГ (CH) |
Макроциклические соединения, применимые в качестве ингибиторов васе
|
|
CA2657280A1
(en)
|
2006-07-20 |
2008-01-24 |
Novartis Ag |
Macrocyclic compounds useful as bace inhibitors
|
|
CA2669839A1
(en)
|
2006-11-23 |
2008-05-29 |
Novartis Ag |
2-hydroxy-1,3-diaminopropane derivatives
|
|
AU2007332750A1
(en)
|
2006-12-12 |
2008-06-19 |
Schering Corporation |
Aspartyl protease inhibitors containing a tricyclic ring system
|
|
JP2010512389A
(ja)
|
2006-12-12 |
2010-04-22 |
シェーリング コーポレイション |
アスパルチルプロテアーゼ阻害剤
|
|
TW200831091A
(en)
*
|
2006-12-20 |
2008-08-01 |
Astrazeneca Ab |
New compounds
|
|
US8148390B2
(en)
*
|
2007-03-12 |
2012-04-03 |
Merck, Sharp & Dohme, Corp. |
Monocyclic anilide spirolactam CGRP receptor antagonists
|
|
CL2008000784A1
(es)
|
2007-03-20 |
2008-05-30 |
Wyeth Corp |
Compuestos amino-5-[-4-(diflourometoxi) fenil sustituido]-5-fenilmidazolona, inhibidores de b-secretasa; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar alzheimer, deterioro cognitivo, sindrome de down, disminucion co
|
|
TW200902499A
(en)
|
2007-05-15 |
2009-01-16 |
Astrazeneca Ab |
New compounds
|
|
US20090041201A1
(en)
|
2007-08-06 |
2009-02-12 |
Carestream Health, Inc. |
Alignment apparatus for imaging system
|
|
EP2190833A1
(en)
|
2007-08-23 |
2010-06-02 |
Novartis Ag |
Aminobenzyl-substituted cyclic sulfones useful as bace inhibitors
|
|
US20090062361A1
(en)
|
2007-08-30 |
2009-03-05 |
Allergan, Inc. |
Therapeutic hydantoins
|
|
TWI431004B
(zh)
|
2008-05-02 |
2014-03-21 |
Lilly Co Eli |
Ｂａｃｅ抑制劑
|
|
KR20110050616A
(ko)
|
2008-07-10 |
2011-05-16 |
노파르티스 아게 |
Ｂａｃｅ 억제제로서 유용한 아미노벤질 치환을 갖는 시클릭 술폰
|
|
EP2360155A4
(en)
|
2008-10-22 |
2012-06-20 |
Shionogi & Co |
2-AMINOPYRIDIN-4-ON AND 2-AMINOPYRIDINE DERIVATIVE WITH BACE1-HEMDERING EFFECT
|
|
EA020784B1
(ru)
|
2008-11-11 |
2015-01-30 |
СиЭсПиСи ЧЖУНЦИ ФАРМАСЬЮТИКЛ ТЕКНОЛОДЖИ (ШИЦЯЧЖУАН) КО., ЛТД. |
Комплекс включения пиноцембрина с циклодекстрином, способ его получения и применения
|
|
AR077277A1
(es)
|
2009-07-09 |
2011-08-17 |
Lilly Co Eli |
Compuestos de biciclo (1,3)tiazin-2-amina formulacion farmaceutica que lo comprende y su uso para la manufactura de un medicamento util para el tratamiento de la enfermedad de alzheimer
|
|
EP2485591B1
(en)
|
2009-10-08 |
2016-03-23 |
Merck Sharp & Dohme Corp. |
Iminothiadiazine dioxide compounds as bace inhibitors, compositions, and their use
|
|
UA108363C2
(uk)
|
2009-10-08 |
2015-04-27 |
|
Похідні імінотіадіазиндіоксиду як інгібітори bace, композиція на їх основі і їх застосування
|
|
US10449177B2
(en)
|
2010-08-19 |
2019-10-22 |
Buck Institute For Research On Aging |
Methods of treating mild cognitive impairment (MCI) and related disorders
|
|
US8415483B2
(en)
|
2010-12-22 |
2013-04-09 |
Astrazeneca Ab |
Compounds and their use as BACE inhibitors
|
|
US20120165346A1
(en)
|
2010-12-22 |
2012-06-28 |
Astrazeneca Ab |
Compounds and their use as BACE inhibitors
|
|
US8877744B2
(en)
|
2011-04-04 |
2014-11-04 |
Hoffmann-La Roche Inc. |
1,4-Oxazepines as BACE1 and/or BACE2 inhibitors
|
|
ES2769578T3
(es)
|
2013-02-12 |
2020-06-26 |
Buck Inst Res Aging |
Hidantoínas que modulan el procesamiento de APP mediado por BACE
|
|
KR20180090778A
(ko)
*
|
2015-08-27 |
2018-08-13 |
난트뉴로, 엘엘씨 |
App-선택적 bace 억제를 위한 조성물 및 그의 용도
|